Filing Details

Accession Number:
0001179110-18-004050
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-12 16:33:04
Reporting Period:
2018-03-08
Accepted Time:
2018-03-12 16:33:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651561 Tabula Rasa Healthcare Inc. TRHC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352929 Bruce Luehrs 4801 S. Broad St.
Suite 400
Philadelphia PA 19112
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-03-08 7,469 $37.04 223,016 No 4 S Indirect See footnotes
Common Stock Disposition 2018-03-09 8,195 $37.13 214,821 No 4 S Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnotes
No 4 S Indirect See footnotes
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,161 Direct
Footnotes
  1. Includes a restricted stock award of 3,710 shares of the Company's common stock received by Bruce Luehrs on September 28, 2016, of which shares 1,236 are vested and 2,474 are unvested. Also includes a restricted stock award of 1,855 shares of the Company's common stock received by Bruce Luehrs on September 28, 2016, all of which are vested. Also includes a restricted stock award of 2,596 shares of the Company's common stock received by Bruce Luehrs on June 16, 2017. Such common stock vests in full on the earlier of the next annual shareholder meeting or the one year anniversary of the date of grant.
  2. These securities are held by Emerald Stage2Ventures, L.P. Stage2 Capital Ventures Associates, L.P. is the general partner of Emerald Stage2 Ventures, L.P. and Stage2 Capital Associates G.P., LLC is the general partner of Stage2 Capital Ventures Associates, L.P. Bruce Luehrs, who serves as a director of the Issuer, is an officer of Stage2 Capital Associates G.P., LLC.
  3. The Reporting Person disclaims beneficial ownership (as defined in Rule 16a-1(a)(2)) of the securities reported herein (except to the extent of his pecuniary interest in such securities), and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
  4. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Emerald Stage2Ventures, L.P. on January 26, 2018.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $37.00 to $37.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (5) to this Form 4.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $37.00 to $37.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (6) to this Form 4.